Bruker Corporation

BRKRNASDAQ • USD
57.59 USD
↗ 0.28 (0.49%)AT CLOSE (03:59 PM EDT)
57.59
↘ 0.01 (0.01%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
57.59
↘ 0.01 (0.01%)
🔴Market: CLOSED

BRKR is currently priced at $57.59. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place BRKR at a fair price relative to peers.

Technical & fundamental data as of Oct 23, 2026.

Open?$56.93
High?$57.78
Low?$55.32
Prev. Close?$57.31
Volume?1.2M
Avg. Volume?2.3M
VWAP?$57.01
Rel. Volume?0.51x
Bid / Ask
Bid?$55.30 × 100
Ask?$57.58 × 100
Spread?$2.28
Midpoint?$56.44
Valuation & Ratios
Market Cap?8.8B
Shares Out?152.4M
Float?111.3M
Float %?73.1%
P/E Ratio?N/A
P/B Ratio?3.66
EPS?-$0.70
Dividend?0.62%
Ex-Dividend?N/A
News
Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Employees
11.1K
Market Cap
8.8B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-08-04
Address
40 MANNING RD
BILLERICA, MA 01821
Phone: 978663-3660
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
43
Momentum?
21
Short Sent.?
40
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.22Grey
Confidence?77%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.15%High
Short Interest?12.4M
Days to Cover?5.1
Free Float111.3M
Avg Daily Volume2.4M
Settlement Date2026-09-30
Financial Health
Current Ratio?1.85Adequate
Quick Ratio?0.92Weak
Cash Ratio?0.15Low
Debt/Equity?0.76Moderate
ValuationFAIRLY VALUEDvs 5 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
67
S&P
47
3.66FAIR▾
P/S?
Peers
100
S&P
57
2.51CHEAP▾
P/FCF?
Peers
17
S&P
3
136.0PRICEY▾
EV/EBITDA?
Peers
100
S&P
17
24.2HIGH▾
EV/Sales?
Peers
100
S&P
61
2.98CHEAP▾
Returns & Efficiency
ROE?
Peers
17
S&P
11
-4.5%WEAK▾
ROA?
Peers
17
S&P
3
-1.8%WEAK▾
Cash Flow & Enterprise
FCF?$64.5M
Enterprise Value?$10.4B
Fundamentals ratios updated end of day